Ardelyx to Participate at the Jefferies Global Healthcare Conference in London
Ardelyx (Nasdaq: ARDX) management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 4:30 pm GMT / 11:30 am ET. Investors can watch a live webcast via the Events and Presentations page on the Ardelyx website. A replay will be available on the Ardelyx website for 30 days after the event.
The presentation offers a chance to hear management commentary and corporate updates directly; access is through the company website's investor events page.
Ardelyx (Nasdaq: ARDX) la direzione parteciperà a una chiacchierata informale presso la Jefferies Global Healthcare Conference a Londra il mercoledì 19 novembre 2025 alle 16:30 GMT / 11:30 ET. Gli investitori possono guardare una trasmissione webcast in diretta tramite la pagina Eventi e Presentazioni del sito di Ardelyx. Una replica sarà disponibile sul sito di Ardelyx per 30 giorni dopo l'evento.
La presentazione offre l'opportunità di ascoltare direttamente i commenti del management e gli aggiornamenti aziendali; l'accesso avviene tramite la pagina eventi per investitori sul sito dell'azienda.
Ardelyx (Nasdaq: ARDX) la dirección participará en una charla informal en la Conferencia Global de Cuidado de la Salud de Jefferies en Londres el miércoles 19 de noviembre de 2025 a las 4:30 p. m. GMT / 11:30 a. m. ET. Los inversores pueden ver una transmisión en directo a través de la página de Eventos y Presentaciones en el sitio web de Ardelyx. Una repetición estará disponible en el sitio web de Ardelyx durante 30 días después del evento.
La presentación ofrece la oportunidad de escuchar comentarios de la dirección y actualizaciones corporativas directamente; el acceso es a través de la página de eventos para inversores en el sitio web de la empresa.
아델릭스(나스닥: ARDX) 경영진은 런던에서 열리는 Jefferies Global Healthcare Conference에서 2025년 11월 19일 수요일 오후 4:30 GMT / 동부 표준시 11:30에 파이어사이드 대화를 진행할 예정입니다. 투자자들은 Ardelyx 웹사이트의 이벤트 및 발표 페이지를 통해 라이브 생중계를 시청할 수 있습니다. 이벤트 후 Ardelyx 웹사이트에서 30일간 재방송이 제공됩니다.
발표는 경영진의 해설과 회사 업데이트를 직접 들을 수 있는 기회를 제공합니다. 접근은 회사 웹사이트의 투자자 이벤트 페이지를 통해 이루어집니다.
Ardelyx (Nasdaq : ARDX) la direction participera à une discussion informelle lors de la Jefferies Global Healthcare Conference à Londres le mercredi 19 novembre 2025 à 16 h 30 GMT / 11 h 30 HE. Les investisseurs pourront regarder une diffusion en direct via la page Événements et Présentations du site Ardelyx. Une rediffusion sera disponible sur le site Ardelyx pendant 30 jours après l'événement.
Cette présentation offre l'occasion d'entendre directement les commentaires de la direction et les mises à jour de l'entreprise ; l'accès se fait via la page des événements pour les investisseurs sur le site de l'entreprise.
Ardelyx (Nasdaq: ARDX) Management wird an einem fireside chat bei der Jefferies Global Healthcare Conference in London am Mittwoch, dem 19. November 2025 um 16:30 Uhr GMT / 11:30 Uhr ET teilnehmen. Investoren können eine Live-Übertragung über die Seite Veranstaltungen und Präsentationen auf der Ardelyx-Website verfolgen. Eine Wiederholung wird auf der Ardelyx-Website 30 Tage nach der Veranstaltung verfügbar sein.
Die Präsentation bietet die Möglichkeit, direkte Kommentare des Managements und Unternehmensupdates zu hören; der Zugriff erfolgt über die Investor-Events-Seite der Unternehmenswebsite.
آرديليكس (ناسداك: ARDX) ستشارك الإدارة في محادثة حميمية خلال مؤتمر Jefferies للرعاية الصحية العالمية في لندن يوم الأربعاء 19 نوفمبر 2025 الساعة 4:30 مساءً بتوقيت GMT / 11:30 صباحاً بتوقيت ET. يمكن للمستثمرين مشاهدة البث الحي عبر صفحة الفعاليات والعروض على موقع Ardelyx. وستكون هناك إعادة تشغيل متاحة على موقع Ardelyx لمدة 30 يوماً بعد الحدث.
تتيح العرض الفرصة لسماع تعليقات الإدارة وتحديثات الشركة مباشرة؛ الوصول من خلال صفحة فعاليات المستثمرين على موقع الشركة.
- None.
- None.
WALTHAM, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 19, 2025 at 4:30 pm GMT/11:30 am ET.
To access the live webcast of the panel presentation please visit the Events and Presentations page within the Ardelyx website at https://ardelyx.com/. A replay of the fireside chat will be available on the Ardelyx website for 30 days following the event.
About Ardelyx
Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor) as well as early-stage pipeline candidates. The company is developing RDX10531, a next-generation NHE3 inhibitor with potential application across multiple therapeutic areas. Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. For more information, please visit https://ardelyx.com/ and connect with us on X (formerly known as Twitter), LinkedIn and Facebook.
Investor and Media Contacts:
Caitlin Lowie
clowie@ardelyx.com
FAQ
When will Ardelyx (ARDX) present at the Jefferies Global Healthcare Conference in London?
How can investors watch the Ardelyx (ARDX) fireside chat webcast on November 19, 2025?
Will a replay of the Ardelyx (ARDX) Jefferies conference presentation be available?
What time is the Ardelyx (ARDX) presentation for US investors on November 19, 2025?
What topics will Ardelyx (ARDX) management cover at the Jefferies Global Healthcare Conference?
Where can I find the Ardelyx (ARDX) webcast and replay after the Jefferies conference?
